CROI 2024 Abstract eBook

Abstract eBook

Search Term Index

1098 Tenofovir disoproxil fumarate 806, 829, 1141 Teropavimab 120 Test 206, 1084 Testing 1169 Testing technologies 1098 Testosterone 1175 Tfh 321 Thailand 667

Transgender individuals 200, 1020, 1244 Transgender men 1145, 1146, 1175 Transgender women 127, 359, 363, 450, 536, 745, 1021, 1115, 1121, 1126, 1144, 1239 Transinfection 305 Transmission 191, 909, 926 Transmission burst 1065 Transmission cluster 1063, 1064, 1065, 1085 Transmission risk 194, 1064 Transmitted founder 317, 687 Treatment 157, 163, 620, 621, 672, 690, 834, 884 Treatment-experienced 807, 815 Treatment gap 791, 1005 Treatment interruption 530 Treatment outcomes 873, 875, 898, 982 Treatment simplification 642 Trend 784, 840, 1061 Trichomonas vaginalis 1149 Triglyceride 777 TRM cell 500 Tuberculosis 156, 157, 163, 164, 210, 211, 869, 873, 874, 875, 877, 878, 879, 880, 881, 883, 884, 887, 897, 1202 Tubular 828 Type I interferons 542 Type I Interferons 508 Uganda 201, 573, 879, 968, 1206, 1207 UNAIDS 1206 UNAIDS targets 1033 Undetectable equals untransmittable 1214 Treatment as prevention 160 Treatment experienced 631 Tropism 367, 453, 465 Tryptophan 579, 924

US/Mexico Border 1014 USPSTF 1117 V1 loop 368 Vaccination 388, 389, 392, 1208 Vaccination status 849, 860 Vaccine 101, 107, 124, 210, 369, 378, 380, 426, 529 Vaccine development 210 Vaccine effectiveness 382, 383, 397, 398, 847, 849, 857 Vaccine response 377, 383, 673, 729 Vaginal inflammation 1138 Vaginal microbiome 1138 Vascular 564, 568 Vascular injury 564, 568 VB 311 Vedolizumab 832 Veillonella 333 Vertical transmission 175, 709, 904, 927, 980 Vesatolimod 542 VH3739937 633 Vibration-controlled transient elastography 743 VIH-1 972 Violence 1119, 1176, 1226 Viral blip 470, 627 Viral control 121, 180, 361 Viral decay 512 Viral escape 692 Viral evolution 145, 368 Viral failure 613 Viral fitness 175, 692 Viral hepatitis 209, 706 Viral kinetics 311 Viral load 308, 366, 397, 424, 470, 926, 964, 981, 1001, 1036, 1039, 1044, 1206 Viral load suppression 534, 1038, 1040, 1200, 1207 Viral load testing 1082, 1091, 1105, 1106 Viral rebound 201, 482, 492, 669, 1035, 1106 Viral reservoir 138, 740 Viral Subtypes 301 Vaccine safety 209, 1212 Vaccines 133, 363, 392 VACS 601, 1058

Viral suppression 116, 182, 599, 625, 629, 652, 675, 757, 878, 964, 1000, 1002, 1016, 1073, 1183, 1198, 1201, 1204, 1214, 1224, 1231 Viremia 197, 628, 676, 1013, 1036, 1039, 1074, 1106 Viremic 613 Viremic controller 361 Virologic failure 680, 686, 991, 1036, 1097 Virologic response 964 Virology 633 Virulence 141, 311, 1044 VOT 901 Vpr 327 VRC01 381 VRC07-523LS 119, 640 Vulnerable population 700 Wastewater 1062 Wastewater surveillance 1062 Weight 790, 806, 807, 986 Weight change 865 Weight gain 332, 803, 804, 808, 809, 810, 812, 813, 814, 815, 823 Weight loss 797 Welfare 1187 West Africa 987 Wilms' tumor 1 748 WNT signaling 535 Women 123, 170, 183, 200, 566, 788, 793, 822, 1005, 1026, 1118, 1136, 1148 Women's health 1092 Women living with HIV 594, 605, 620, 763, 809, 912, 915, 1004, 1166, 1237 WT1 748 Xpert MTB/RIF 896 Young adults 548, 1126 Young women 1222 Youth living with HIV 189, 968, 979, 985, 1031 Zambia 913, 1127, 1143, 1184 Zimbabwe 1027, 1167 Zinlirvimab 120 Western Hemisphere 1076 White matter 564, 586, 587 White matter hyperintensity 587 WHO weight bands 940 WIHS 788

Therapeutic drug Monitoring 1098 Therapeutic vaccine 407, 446, 506 Third line 680 Thrombomodulin 867 Thrombosis 867 Time-to-rebound 482, 484 Timing of therapy 1178 Tissue 466, 491 Tissue distribution 488, 608 Tissue reservoirs 445, 495, 498 Tixagevimab/cilgavimab 670, 671 TKIs 440 TLD 182, 675, 915 TLR 957

TMB-365 640 TMB-380 640 TNF signaling 794 Tobacco 449 Tolerability 639 Total HIV-1 DNA 467, 515 Toxicity 829, 874 TPOXX 419 TPT 878, 879 Trafficking 491

Trained immunity 442 Transactional sex 1119 Transcription 113, 469, 472, 646 Transcription factor 478 Transcription start site 139 Transcriptional elongation 300 transcriptional HIV-1 RNA 467, 476 Transcriptional interference 458 Transcriptionally active proviruses 468 Transcriptome 400, 405, 541, 885

Undisclosed ART 1202 United Kingdom 935 United States 1074 Universal test and treat 1178 Unusual subtypes 713

Uptake 396, 1209 Urine assay 1113

Urine drug detection 614, 1112, 1198, 1231 Urine tenofovir 167, 652, 1114, 1198, 1202, 1231

Transcriptomic 352 Transgender 1020

Search Term Index

CROI 2024 444